60 DEGREES PHARMA INC (SXTP) Stock Analyst Earnings Estimates
NASDAQ:SXTP - Nasdaq - US83006G4010 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 511.2K -91.95% | 253.6K -50.39% | 681.4K 168.69% | 1.236M 81.39% | 2.418M 95.63% | 3.857M 59.51% | |
| EBITDA YoY % growth | -1.718M -57.10% | -5.104M -197.18% | -9.665M -89.34% | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.75M -55.72% | -5.155M -194.48% | -9.715M -88.47% | -7.181M 26.08% | -7.055M 1.75% | -5.881M 16.64% | |
| Operating Margin | -342.41% | -2,032.57% | -1,425.73% | -581.01% | -291.78% | -152.48% | |
| EPS YoY % growth | N/A | N/A | -38.20 30.26% | -2.19 94.26% | -3.11 -41.63% | -0.48 84.56% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.98 95.37% | -0.85 81.79% | -0.73 94.83% | -1.35 13.69% | -1.38 -40.63% | -1.54 -81.93% | -1.50 -104.17% |
| Revenue Q2Q % growth | 307.02K 145.62% | 375.87K 178.42% | 417.69K 80.82% | 489.6K 200.37% | 510K 66.11% | 612K 62.82% | 612K 46.52% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -1.784M 57.41% | -1.756M 17.12% | -1.675M 19.29% | -1.856M 2.85% | -2.04M -14.35% | -2.244M -27.80% | -2.244M -33.94% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -1.56 -186.67% | -1.34 | -0.22 | -16.31% |
| Q4 2024 Q2Q % growth | -14.20 34.26% | -4.09 | -10.11 | -247.17% |
| Q3 2024 Q2Q % growth | -4.65 -110.06% | -3.60 | -1.05 | -29.33% |
| Q2 2024 Q2Q % growth | -21.15 | -14.25 | -6.90 | -48.37% |
| Q1 2024 Q2Q % growth | 1.80 | -9.18 | 10.98 | 119.61% |
| Q4 2023 Q2Q % growth | -21.60 | -12.55 | -9.05 | -72.17% |
| Q3 2023 Q2Q % growth | 46.20 | 58.14 | -11.94 | -20.54% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 163K 11.58% | 231.54K | -68.54K | -29.60% |
| Q4 2024 Q2Q % growth | 231K 440.86% | 238.68K | -7.68K | -3.22% |
| Q3 2024 Q2Q % growth | 135K 164.71% | 246.84K | -111.84K | -45.31% |
| Q2 2024 Q2Q % growth | 125K 99.36% | 215.73K | -90.73K | -42.06% |
| Q1 2024 Q2Q % growth | 146.09K 579.49% | 164.22K | -18.13K | -11.04% |
| Q4 2023 Q2Q % growth | 42.71K -91.65% | 76.5K | -33.79K | -44.17% |
| Q3 2023 Q2Q % growth | 51K -90.87% | 89.25K | -38.25K | -42.86% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 2.04% | 0% | 42.44% |
| Revenue | 0% | 0% | 0% | -7.21% |